Differentiated Thyroid Cancer (DTC)
Oncology
4 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| CABOMETYX | EXELIXIS, INC. (EXEL) |
Phase 3(1)
| Drug | Company |
|---|---|
| dabrafenib | Novartis AG (NVS) |
Phase 4(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Differentiated Thyroid Cancer (DTC)?
BioSniper tracks 4 drugs in development for Differentiated Thyroid Cancer (DTC) across 2 companies.
How many clinical trials target Differentiated Thyroid Cancer (DTC)?
There are 2 clinical trials targeting Differentiated Thyroid Cancer (DTC) tracked by BioSniper.
Deep-dive into Differentiated Thyroid Cancer (DTC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis